You are here

Article info

Article menu

Download PDFPDF

Cervical cancer
2022-RA-905-ESGO Mismatch repair deficiency is not applicable as biomarker in cervical cancer, yet MSH-2 has strong prognostic value
Free

Authors

  • Madeleine Charlotte van den Berg Department of Obstetrics and Gynaecology, Haukeland university hospital, Bergen, Norway Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway PubMed articlesGoogle scholar articles
  • Hege Fredriksen Berg Department of Obstetrics and Gynaecology, Haukeland university hospital, Bergen, Norway Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway PubMed articlesGoogle scholar articles
  • Thomas Stokowy Genomics Core Facility, Department of Clinical Science, University of Bergen, Bergen, Norway PubMed articlesGoogle scholar articles
  • Erling Hoivik Department of Obstetrics and Gynaecology, Haukeland university hospital, Bergen, Norway Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway PubMed articlesGoogle scholar articles
  • Kathrine Woie Department of Obstetrics and Gynaecology, Haukeland university hospital, Bergen, Norway PubMed articlesGoogle scholar articles
  • Hilde Engerud Department of Obstetrics and Gynaecology, Haukeland university hospital, Bergen, Norway Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway PubMed articlesGoogle scholar articles
  • Akinyemi I Ojesina Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL O’Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL HudsonAlpha Institute for Biotechnology, Huntsville, AL PubMed articlesGoogle scholar articles
  • Ingfrid Helene Salvesen Haldorsen Department of Radiology, Mohn Medical Imaging and Visualization Centre, Haukeland university hospital, Bergen, Norway Department of Clinical Medicine, University of Bergen, Bergen, Norway PubMed articlesGoogle scholar articles
  • Bjørn Inge Bertelsen Department of Pathology, Haukeland university hospital, Bergen, Norway PubMed articlesGoogle scholar articles
  • Jone Trovik Department of Obstetrics and Gynaecology, Haukeland university hospital, Bergen, Norway Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway PubMed articlesGoogle scholar articles
  • Mari Kyllesø Halle Department of Obstetrics and Gynaecology, Haukeland university hospital, Bergen, Norway PubMed articlesGoogle scholar articles
  • Camilla Krakstad Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway Department of Obstetrics and Gynaecology, Haukeland university hospital, Bergen, Norway Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway PubMed articlesGoogle scholar articles

Citation

van den Berg MC, Berg HF, Stokowy T, et al
2022-RA-905-ESGO Mismatch repair deficiency is not applicable as biomarker in cervical cancer, yet MSH-2 has strong prognostic value
International Journal of Gynecologic Cancer 2022;32:A32.

Publication history

  • First published October 20, 2022.
Online issue publication 
October 27, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ.